Synopsys, Inc. (NASDAQ:SNPS) Expected to Post Earnings of $1.52 Per Share


Share on StockTwits

Wall Street analysts expect that Synopsys, Inc. (NASDAQ:SNPS) will announce earnings of $1.52 per share for the current fiscal quarter, according to Zacks Investment Research. Four analysts have issued estimates for Synopsys’ earnings. The highest EPS estimate is $1.55 and the lowest is $1.50. Synopsys reported earnings of $1.22 per share during the same quarter last year, which would indicate a positive year-over-year growth rate of 24.6%. The company is scheduled to issue its next earnings results on Wednesday, May 19th.

On average, analysts expect that Synopsys will report full year earnings of $6.29 per share for the current fiscal year, with EPS estimates ranging from $6.25 to $6.34. For the next financial year, analysts expect that the firm will report earnings of $7.12 per share, with EPS estimates ranging from $6.92 to $7.25. Zacks Investment Research’s earnings per share averages are an average based on a survey of research analysts that that provide coverage for Synopsys.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings results on Wednesday, February 17th. The semiconductor company reported $1.52 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.07 by $0.45. Synopsys had a return on equity of 14.81% and a net margin of 18.03%. The firm had revenue of $970.32 million during the quarter, compared to analyst estimates of $952.24 million. During the same quarter in the previous year, the company posted $1.01 earnings per share.

A number of equities research analysts have recently weighed in on the company. Bank of America lowered Synopsys from a “buy” rating to a “neutral” rating in a research note on Monday, January 11th. Needham & Company LLC boosted their target price on Synopsys from $275.00 to $310.00 and gave the company a “buy” rating in a research note on Thursday, February 25th. KeyCorp boosted their price target on Synopsys from $315.00 to $320.00 and gave the company an “overweight” rating in a report on Thursday, February 25th. DA Davidson boosted their price target on Synopsys from $285.00 to $335.00 and gave the company a “buy” rating in a report on Thursday, February 18th. Finally, Royal Bank of Canada boosted their price target on Synopsys from $250.00 to $330.00 and gave the company an “outperform” rating in a report on Tuesday, February 16th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and ten have given a buy rating to the company. Synopsys currently has a consensus rating of “Buy” and a consensus price target of $279.75.

In related news, CEO Geus Aart De sold 28,311 shares of the firm’s stock in a transaction on Friday, March 26th. The stock was sold at an average price of $241.42, for a total value of $6,834,841.62. Following the transaction, the chief executive officer now directly owns 93,848 shares of the company’s stock, valued at approximately $22,656,784.16. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider John F. Runkel, Jr. sold 4,236 shares of the firm’s stock in a transaction on Wednesday, March 24th. The stock was sold at an average price of $238.00, for a total value of $1,008,168.00. Following the completion of the transaction, the insider now directly owns 21,725 shares in the company, valued at $5,170,550. The disclosure for this sale can be found here. Insiders have sold a total of 92,030 shares of company stock worth $23,699,496 over the last three months. Insiders own 1.84% of the company’s stock.

Institutional investors have recently modified their holdings of the company. MPS Loria Financial Planners LLC bought a new position in shares of Synopsys in the 4th quarter valued at about $25,000. Liberty Wealth Management LLC lifted its holdings in shares of Synopsys by 92.3% in the 4th quarter. Liberty Wealth Management LLC now owns 100 shares of the semiconductor company’s stock valued at $26,000 after acquiring an additional 48 shares during the last quarter. Catalyst Capital Advisors LLC bought a new position in shares of Synopsys in the 4th quarter valued at about $28,000. Baillie Gifford & Co. bought a new position in shares of Synopsys in the 4th quarter valued at about $33,000. Finally, Northwest Investment Counselors LLC bought a new position in shares of Synopsys in the 1st quarter valued at about $36,000. Hedge funds and other institutional investors own 86.11% of the company’s stock.

Shares of NASDAQ SNPS traded down $8.75 during midday trading on Thursday, reaching $236.06. The company had a trading volume of 17,468 shares, compared to its average volume of 907,930. Synopsys has a one year low of $147.98 and a one year high of $300.91. The company has a quick ratio of 1.10, a current ratio of 1.19 and a debt-to-equity ratio of 0.02. The firm’s fifty day moving average price is $248.12 and its 200-day moving average price is $246.43. The stock has a market cap of $35.97 billion, a PE ratio of 57.47, a price-to-earnings-growth ratio of 5.07 and a beta of 1.10.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It offers Fusion Design Platform, a digital design implementation solution; Verification Continuum Platform that provides virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Read More: How Do You Calculate Return on Equity (ROE)?

Get a free copy of the Zacks research report on Synopsys (SNPS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.